62 related articles for article (PubMed ID: 11726200)
1. Wild-type and mutated nicastrins do not display aminopeptidase M- and B-like activities.
Fergani A; Yu G; St George-Hyslop P; Checler F
Biochem Biophys Res Commun; 2001 Dec; 289(3):678-80. PubMed ID: 11726200
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
3. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
4. [Molecular basics of Alzheimer's disease].
Grigorenko AP; Rogaev EI
Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
[TBL] [Abstract][Full Text] [Related]
5. Nicastrin, a presenilin-interacting protein, contains an aminopeptidase/transferrin receptor superfamily domain.
Fagan R; Swindells M; Overington J; Weir M
Trends Biochem Sci; 2001 Apr; 26(4):213-4. PubMed ID: 11295540
[TBL] [Abstract][Full Text] [Related]
6. Neprilysin activity and expression are controlled by nicastrin.
Pardossi-Piquard R; Dunys J; Yu G; St George-Hyslop P; Alves da Costa C; Checler F
J Neurochem; 2006 May; 97(4):1052-6. PubMed ID: 16606360
[TBL] [Abstract][Full Text] [Related]
7. Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells.
Esposito L; Gan L; Yu GQ; Essrich C; Mucke L
J Neurochem; 2004 Dec; 91(6):1260-74. PubMed ID: 15584903
[TBL] [Abstract][Full Text] [Related]
8. Baculoviruses expressing the human familial Alzheimer's disease presenilin 1 mutation lacking exon 9 increase levels of an amyloid beta-like protein in Sf9 cells.
Verdile G; Groth D; Mathews PM; St George-Hyslop P; Fraser PE; Ramabhadran TV; Kwok JB; Schofield PR; Carter T; Gandy S; Martins RN
Mol Psychiatry; 2004 Jun; 9(6):594-602. PubMed ID: 14993906
[TBL] [Abstract][Full Text] [Related]
9. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
10. Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide.
Sevalle J; Amoyel A; Robert P; Fournié-Zaluski MC; Roques B; Checler F
J Neurochem; 2009 Apr; 109(1):248-56. PubMed ID: 19187443
[TBL] [Abstract][Full Text] [Related]
11. The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells.
Lessard CB; Lussier MP; Cayouette S; Bourque G; Boulay G
Cell Signal; 2005 Apr; 17(4):437-45. PubMed ID: 15601622
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
[TBL] [Abstract][Full Text] [Related]
13. Refining structural and functional predictions for secretasome components by comparative sequence analysis.
Mushegian A
Proteins; 2002 Apr; 47(1):69-74. PubMed ID: 11870866
[TBL] [Abstract][Full Text] [Related]
14. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease.
Yu WH; Kumar A; Peterhoff C; Shapiro Kulnane L; Uchiyama Y; Lamb BT; Cuervo AM; Nixon RA
Int J Biochem Cell Biol; 2004 Dec; 36(12):2531-40. PubMed ID: 15325590
[TBL] [Abstract][Full Text] [Related]
15. Two domains within the first putative transmembrane domain of presenilin 1 differentially influence presenilinase and gamma-secretase activity.
Brunkan AL; Martinez M; Wang J; Walker ES; Beher D; Shearman MS; Goate AM
J Neurochem; 2005 Sep; 94(5):1315-28. PubMed ID: 16001967
[TBL] [Abstract][Full Text] [Related]
16. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins.
Schaeffer V; Patte-Mensah C; Eckert A; Mensah-Nyagan AG
J Neurobiol; 2006 Jul; 66(8):868-81. PubMed ID: 16673391
[TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
19. Conserved residues in juxtamembrane region of the extracellular domain of nicastrin are essential for gamma-secretase complex formation.
Walker ES; Martinez M; Wang J; Goate A
J Neurochem; 2006 Jul; 98(1):300-9. PubMed ID: 16805816
[TBL] [Abstract][Full Text] [Related]
20. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
